← Eichor
Study identifier: NCT05826158 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

Condition: Neuroblastoma  ·  Sponsor: Rigshospitalet, Denmark

PhaseNA
Planned participants25
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

This is a study evaluating the positron-emitting radiopharmaceutical 18F-mFBG compared to 123I-mIBG scintigraphy for imaging of neuroblastoma

This description comes directly from the study's public registry record.

Talk to the study team

Lise Borgwardt, MD, PhD.  ·  +4535459568  ·  lise.borgwardt@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Rigshospitalet, Copenhagen University HospitalCopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05826158